MyAverix Finance
SHG · Healthcare
Jiangsu Lianhuan Pharmaceutical Co Ltd (600513)
Drug Manufacturers - Specialty & Generic
Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600513
Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) — FAQ
What is 600513's P/E ratio?
The price-to-earnings (P/E) ratio for Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) is 18.00 (data as of 2026-05-23).
Does Jiangsu Lianhuan Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Jiangsu Lianhuan Pharmaceutical Co Ltd (600513). Check the MyAverix Finance app for the latest dividend data.
What sector is Jiangsu Lianhuan Pharmaceutical Co Ltd in?
Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 600513 listed on?
600513 is listed on SHG.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.